MRPHF - Marapharm Ventures Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.23
-0.02 (-8.91%)
As of 3:43PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.25
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume519,383
Market Cap55.295M
Beta (3Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)-0.16
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Liht Cannabis Corp. undergoes management shuffle
    PR Newswire25 days ago

    Liht Cannabis Corp. undergoes management shuffle

    KELOWNA, BC, Oct. 25, 2018 /PRNewswire/ - Liht Cannabis Corp. (CSE:LIHT) (OTCQX:LIHTF) (2M0.F) ("Liht" or the "Company") a public company with medical and adult-use cannabis assets in the United States and Canada announces a corporate management shuffle. As the Company continues to grow into new phases of its business plan, signaled by the transitioning into cultivation in Nevada and the submission of an ACMPR application in Canada, the roles of leadership will be critical in being successful. To better manage the day to day operations involved with a public cannabis company, Linda Sampson will remain the President and become the Chief Operating Officer ("COO") and Rahim Mohamed will be appointed as Chief Executive Officer ("CEO"), effective immediately.

  • Marapharm Ventures Inc. Changes Name to Liht Cannabis Corp. ("Liht")
    PR Newswire26 days ago

    Marapharm Ventures Inc. Changes Name to Liht Cannabis Corp. ("Liht")

    No action is required to be taken by current shareholders in connection with the change, and no change has been made to Liht Cannabis Corp. share capital. The Company's common shares are expected to commence trading on the Canadian Securities Exchange (the "CSE") under the new symbol "LIHT" on or about October 25th, 2018. The Company will keep its U.S. and European shareholders advised by news release of changes to their market's ticker symbol.

  • Marapharm Ventures Inc. Changes Name to Liht Cannabis Corp. ("Liht")
    CNW Group26 days ago

    Marapharm Ventures Inc. Changes Name to Liht Cannabis Corp. ("Liht")

    No action is required to be taken by current shareholders in connection with the change, and no change has been made to Liht Cannabis Corp. share capital. The Company's common shares are expected to commence trading on the Canadian Securities Exchange (the "CSE") under the new symbol "LIHT" on or about October 25 th, 2018. The Company will keep its U.S. and European shareholders advised by news release of changes to their market's ticker symbol.

  • CNW Group27 days ago

    Marapharm Ventures Inc. closes over-subscribed debenture and extends January 31, 2019 Warrants by one year

    KELOWNA, BC , Oct. 23, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") wishes to announce that further to its news release on September 26, 2018 , the Company has closed over-subscribed on the non-brokered unsecured debenture financing ("Debenture Offering") through the issuance of CDN$3,263,093 principal number of debentures (the "Debentures"). The Debentures shall be convertible into units ("Debenture Units") of the Company at a conversion of $0.20 per Debenture Unit. Each unit will be comprised of one Common Share of the Company and one Common Share Purchase Warrant exercisable at $0.50 for one year from the date of issuance.

  • PR Newswire27 days ago

    Marapharm Ventures Inc. closes over-subscribed debenture and extends January 31, 2019 Warrants by one year

    KELOWNA, BC, Oct. 23, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") wishes to announce that further to its news release on September 26, 2018, the Company has closed over-subscribed on the non-brokered unsecured debenture financing ("Debenture Offering") through the issuance of CDN$3,263,093 principal number of debentures (the "Debentures"). The Debentures shall be convertible into units ("Debenture Units") of the Company at a conversion of $0.20 per Debenture Unit. Each unit will be comprised of one Common Share of the Company and one Common Share Purchase Warrant exercisable at $0.50 for one year from the date of issuance.

  • Marapharm Ventures Inc. announces final approval from the State of Nevada for first facility
    CNW Group28 days ago

    Marapharm Ventures Inc. announces final approval from the State of Nevada for first facility

    KELOWNA, BC , Oct. 22, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to announce to its shareholders, that further to its news release of October 17, 2018 , its first facility has been granted the final approval to commence operations, from the State of Nevada . On Friday October 19 th, the State of Nevada completed their final inspection of the first 5,000 sq. ft facility which is designated to the Company's Phenofarm Cultivation Licence. All permitting is complete for this licence and the final approval now allows for the immediate transition of plants to the new facility to complete their cycle and provide first harvest.

  • Marapharm Ventures Inc. announces final approval from the State of Nevada for first facility
    PR Newswire28 days ago

    Marapharm Ventures Inc. announces final approval from the State of Nevada for first facility

    KELOWNA, BC, Oct. 22, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to announce to its shareholders, that further to its news release of October 17, 2018, its first facility has been granted the final approval to commence operations, from the State of Nevada. On Friday October 19th, the State of Nevada completed their final inspection of the first 5,000 sq. ft facility which is designated to the Company's Phenofarm Cultivation Licence. All permitting is complete for this licence and the final approval now allows for the immediate transition of plants to the new facility to complete their cycle and provide first harvest.

  • PR Newswirelast month

    Marapharm Ventures Inc. Receives Temporary Certificate of Occupancy, North Las Vegas Cultivation Facilities

    KELOWNA, BC, Oct .17, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is pleased to announce to its shareholders that it has received a temporary Certificate of Occupancy from the City of North Las Vegas. Today, the Company received the temporary Certificate of Occupancy from the City of North Las Vegas evidencing the completion of all local permitting. This milestone now allows for the State of Nevada to perform its final inspection and approval so that cultivation and production can commence in the new facilities.

  • Marapharm Ventures Inc. Receives Temporary Certificate of Occupancy, North Las Vegas Cultivation Facilities
    CNW Grouplast month

    Marapharm Ventures Inc. Receives Temporary Certificate of Occupancy, North Las Vegas Cultivation Facilities

    KELOWNA, BC , Oct .17, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is pleased to announce to its shareholders that it has received a temporary Certificate of Occupancy from the City of North Las Vegas . Today, the Company received the temporary Certificate of Occupancy from the City of North Las Vegas evidencing the completion of all local permitting. This milestone now allows for the State of Nevada to perform its final inspection and approval so that cultivation and production can commence in the new facilities.

  • CNW Grouplast month

    Marapharm Ventures Inc. appoints Director and expands its Management Advisory Board

    KELOWNA, BC , Oct. 17, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to appoint a fourth Director to the Board and further expands its Management Advisory Board. Mr. Huhn has over 15 years experience in project management, development, planning, design and construction of gold, palladium, platinum and rhodium mines in Western Canada , optimizing the life of mine production. In 2016, Mr. Huhn established Full Circle PGM Innovations to focus on a series of mining ventures incorporating proprietary and innovative technologies to achieve fine gold and PGM extractions resulting in the ability to extract on a nano-soluble level.

  • PR Newswirelast month

    Marapharm Ventures Inc. appoints Director and expands its Management Advisory Board

    KELOWNA, BC, Oct. 17, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to appoint a fourth Director to the Board and further expands its Management Advisory Board. Mr. Huhn has over 15 years experience in project management, development, planning, design and construction of gold, palladium, platinum and rhodium mines in Western Canada, optimizing the life of mine production. In 2016, Mr. Huhn established Full Circle PGM Innovations to focus on a series of mining ventures incorporating proprietary and innovative technologies to achieve fine gold and PGM extractions resulting in the ability to extract on a nano-soluble level.

  • PR Newswirelast month

    Marapharm Ventures Inc. Congratulates Canada - First G7 nation to legalize adult-use of cannabis for recreational purposes

    KELOWNA, BC, Oct. 17, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") shares its exhilaration with Canadians on this historic day of the legalization of recreational cannabis. The governmental agency Health Canada estimates annual demand in the country to be 926,000 kilograms, or about 2 million pounds. "We have shared a common goal for the legalization of cannabis and today it is a reality.

  • CNW Grouplast month

    Marapharm Ventures Inc. Congratulates Canada - First G7 nation to legalize adult-use of cannabis for recreational purposes

    Marapharm Ventures Inc. Congratulates Canada - First G7 nation to legalize adult-use of cannabis for recreational purposes

  • CNW Grouplast month

    Marapharm Ventures Inc. assembles advisory board to accelerate its strategic action plan

    Marapharm Ventures Inc. assembles advisory board to accelerate its strategic action plan

  • PR Newswirelast month

    Marapharm Ventures Inc. assembles advisory board to accelerate its strategic action plan

    KELOWNA, BC, Oct. 9, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") announced today that it has begun to assemble a strategic Management Advisory Board (MAB). Dr. Paul Hornby, of Hedron Analytical Inc., is Canada's Cannabis Expert. With a doctorate degree in human pathology, Dr. Hornby has conducted research projects with Inuit in the Canadian Arctic, fishermen on India's south coast and Mangyan people in the mountains of Mindoro, Philippines.

  • CNW Group2 months ago

    Marapharm Ventures Inc. Announces Health Canada ACMPR Application Update

    KELOWNA, BC , Oct. 3, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to announce, the Company has submitted the necessary amendments to its late-stage, Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR") application. The Company is honored that Mr. Gabriel Cipes has accepted the appointment of Head of Quality Assurance and has approved the Company's amendments to the Quality Assurance portion of its application. Mr. Cipes is Vice President of Summerhill Pyramid Winery, one of the largest certified organic wineries in Canada .

  • Marapharm Ventures Inc. Closes Acquisition of Full Spectrum Medicinal Inc. & Announces Debenture Financing
    PR Newswire2 months ago

    Marapharm Ventures Inc. Closes Acquisition of Full Spectrum Medicinal Inc. & Announces Debenture Financing

    KELOWNA, BC, Sept. 26, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to announce, further to its news releases dated June 25 and August 21, 2018, the Company has completed its due diligence and has completed the acquisition (the "Acquisition") of all outstanding securities of Full Spectrum Medicinal Inc. ("FSM"). FSM's organic cultivation methods, stand-alone proprietary technologies and supplemental power are intended to reduce our carbon footprint, cost of production and improve profitability.  We will benefit by setting new industry standards for cultivating premium cannabis products on a commercial scale. On September 25, 2018, the Company signed the Definitive Agreement and has completed the Acquisition pursuant to a share exchange agreement made effective as of September 25, 2018 (the "Acquisition Agreement") among the Company, FSM and the shareholders of FSM (the "Selling Shareholders"), whereby the Company issued a total of 88,182,102 common shares of the Company, at a deemed price of $0.31 per share to the Selling Shareholders in exchange for all of the outstanding common shares of FSM.

  • Marapharm Ventures Inc. Closes Acquisition of Full Spectrum Medicinal Inc. & Announces Debenture Financing
    CNW Group2 months ago

    Marapharm Ventures Inc. Closes Acquisition of Full Spectrum Medicinal Inc. & Announces Debenture Financing

    KELOWNA, BC , Sept. 26, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is very pleased to announce, further to its news releases dated June 25 and August 21, 2018 , the Company has completed its due diligence and has completed the acquisition (the "Acquisition") of all outstanding securities of Full Spectrum Medicinal Inc. ("FSM"). FSM's organic cultivation methods, stand-alone proprietary technologies and supplemental power are intended to reduce our carbon footprint, cost of production and improve profitability.  We will benefit by setting new industry standards for cultivating premium cannabis products on a commercial scale. On September 25, 2018 , the Company signed the Definitive Agreement and has completed the Acquisition pursuant to a share exchange agreement made effective as of September 25, 2018 (the "Acquisition Agreement") among the Company, FSM and the shareholders of FSM (the "Selling Shareholders"), whereby the Company issued a total of 88,182,102 common shares of the Company, at a deemed price of $0.31 per share to the Selling Shareholders in exchange for all of the outstanding common shares of FSM.

  • CNW Group2 months ago

    Marapharm Ventures Inc. declares success during California regulatory transition at its dispensary in Desert Hot Springs

    Marapharm Ventures Inc. declares success during California regulatory transition at its dispensary in Desert Hot Springs

  • PR Newswire2 months ago

    Marapharm Ventures Inc. declares success during California regulatory transition at its dispensary in Desert Hot Springs

    KELOWNA, BC, Sept. 14, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") is pleased to report that Green Leaf Wellness Dispensary made profitable progress during the six-month California regulatory transition period to MAUCRSA (Medicinal and Adult-Use Cannabis Regulation and Safety Act). Management and staff at Green Leaf Wellness Dispensary took exemplary measures to prepare for the new regulations and have shown increase to profits and higher traffic volumes. Many dispensaries in the surrounding area suffered losses and were forced to close, due to lack of planning and access to compliant product.

  • PR Newswire2 months ago

    Marapharm Ventures Inc. Updates shareholders on its North Las Vegas, Nevada facilities

    KELOWNA, BC, Sept. 12, 2018 /PRNewswire/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") provides an update to shareholders on the status of permitting for final occupancy and continued cultivation in the temporary buildings.

  • CNW Group2 months ago

    Marapharm Ventures Inc. Updates shareholders on its North Las Vegas, Nevada facilities

    Marapharm Ventures Inc. Updates shareholders on its North Las Vegas, Nevada facilities

  • PR Newswire3 months ago

    Marapharm Ventures Inc. Announces a Fully Funded Operating Agreement with Full Spectrum Medicinal Inc. ("FSM") and updates Shareholders on its Health Canada ACMPR Application

    KELOWNA, BC , Aug. 21, 2018 /PRNewswire/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") a public company with substantial medical and ...

  • CNW Group3 months ago

    Marapharm Ventures Inc. Announces a Fully Funded Operating Agreement with Full Spectrum Medicinal Inc. ("FSM") and updates Shareholders on its Health Canada ACMPR Application

    Marapharm Ventures Inc. Announces a Fully Funded Operating Agreement with Full Spectrum Medicinal Inc. ("FSM") and updates Shareholders on its Health Canada ACMPR Application

  • CNW Group3 months ago

    Marapharm Ventures Inc. Updates Shareholders on Licensing in Nevada

    KELOWNA, BC , Aug. 15, 2018 /CNW/ - Marapharm Ventures Inc. (MDM.CN) (MRPHF) (2M0.F) ("Marapharm" or the "Company") updates shareholders on its proceedings to establish jurisdictional licensing in preparation for the sale of cannabis, once in full production. As reported by news release on July 27, 2018 , cultivation in our temporary buildings continues, allowing us to maintain our production schedule.  Contractors are working with the City of North Las Vegas and the State of Nevada to meet the necessary requirements for the Certificate of Occupancy's. This will permit the Tax Department's final inspection and the transfer of plants to the new facilities. On June 22, 2018 , Marapharm applied for three City of Las Vegas Business Licences.